Related Experiment Video
Updated: Jan 23, 2026

A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury
Published on: March 31, 2023
Biological variation of cardiac markers in patients with aortic valve stenosis
Frederique E C M Peeters1, Bas L J H Kietselaer2, Judith Hilderink3
1Cardiology, Maastricht University Medical Center+ and CARIM, Maastricht, The Netherlands.
Insights
This study quantifies biological variation in cardiac biomarkers for stable aortic valve stenosis (AVS) patients. Understanding these variations aids in accurately interpreting biomarker changes for better AVS management.
Area of Science:
- Cardiology
- Clinical Biochemistry
Background:
- Cardiac biomarkers are crucial for monitoring aortic valve stenosis (AVS).
- Interpreting serial biomarker measurements in AVS patients requires distinguishing true changes from random fluctuations.
- Robust estimation of biological variation is essential for reliable biomarker interpretation.
Purpose of the Study:
- To assess the biological variation of key cardiac biomarkers in patients with stable AVS.
- To provide data for evidence-based interpretation of biomarker changes in AVS follow-up.
- To evaluate B-type natriuretic peptide (BNP), NT-proBNP, hs-TnT, hs-TnI, and ST2 variations.
Main Methods:
- Serial blood sampling from 25 stable AVS patients over one year.
- Measurement of analytical variation (CVA), within-subject biological variation (CVI), and between-subject biological variation (CVG).
- Calculation of the index of individuality (II) and reference change values for each biomarker.
Main Results:
- Within-subject variation (CVI) was highest for BNP (62.0%) and lowest for hs-TnI (9.2%).
- Between-subject variation (CVG) exceeded CVI for all biomarkers except BNP.
- Most biomarkers (NT-proBNP, hs-TnT, ST2) had low analytical variation (<5%), while BNP and hs-TnI had higher CVA.
Conclusions:
- This study presents the first biological variation estimates for cardiac biomarkers in stable AVS patients.
- These estimates facilitate more accurate interpretation of biomarker dynamics during AVS management.
- Understanding biomarker variability improves clinical decision-making in AVS follow-up.
Objective:
Cardiac biomarkers hold promise for follow-up and management of aortic valve stenosis (AVS). When interpreting serial biomarker measurements of patients with AVS, it can be challenging to distinguish 'real changes' from 'random fluctuation'. Hence, robust estimation of the biological variation of these biomarkers is essential. In the present study we assessed biological variation of B-type natriuretic peptide (BNP), N-terminus pro-brain natriuretic peptide (NT-proBNP), high-sensitivity troponin-T and high-sensitivity troponin-I (hs-TnT and hs-TnI), and ST2 in subjects with stable AVS.
Methods:
Serial blood sampling was performed in 25 subjects with moderate AVS-confirmed by echocardiography-and all free from acute cardiovascular events in the past 6 months. Blood samples were taken on seven standardised occasions during 1 year. Analytical variation (CVA), within-subject biological variation (CVI), between-subject biological variation (CVG), index of individuality (II) and reference change values were calculated for all cardiac biomarkers.
Results:
CVI was highest for BNP (62.0%, 95% CI 52.5 to 75.4) and lowest for hs-TnI (9.2%, 95% CI 2.8 to 13.8). CVG exceeded the CVI for all biomarkers except BNP, and ranged from 19.8% (95% CI 13.8 to 33.4) for ST2 to 57.2% (95% CI 40.4 to 97.3) for hs-TnT. NT-proBNP, hs-TnT and ST2 revealed CVA <5%, while BNP and hs-TnI showed a higher CVA (19.7 and 14.9, respectively). All biomarkers except BNP showed marked individuality, with II ranging from 0.21 to 0.67 (BNP 1.34).
Conclusion:
This study provides the first biological variation estimates of cardiac biomarkers in patients with stable AVS. These estimates allow a more evidence-based interpretation of biomarker changes in the follow-up and management of patients with AVS.
Trial Registration Number:
NCT02510482.
More Related Videos
12:17Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
06:51Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
Published on: October 20, 2023
Related Concept Videos
What is Variation?
The range, standard deviation, standard error, and variance are the different measures of variation.
Range: The range is the difference between its maximum and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Variation
When independent and dependent variables are plotted on a scatter plot, the slope of a line is a value that describes the rate of change between the two...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Variation of Atmospheric Pressure
Assuming the air temperature is constant at a given altitude and that the ideal gas law of thermodynamics describes the atmosphere to a good approximation, one can find the variation of atmospheric pressure with height.
Let p(y) be the atmospheric pressure at...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...